Remote Ingestion

Enhancing Patient Experience and Physician Workflow

CapsoCam Plus®, the only capsule endoscopy system offering 360° panoramic imaging, is FDA-cleared for remote ingestion. Eligible patients can conveniently ingest the CapsoCam Plus capsule from the comfort of their homes under virtual medical supervision, representing a transformative advancement in enhancing patient accessibility and comfort in diagnostic procedures for small bowel visualization.

See Eligibility Guidelines

Clinical, Operational, and Financial Impact

  • Preferred by Patients: Study participants report that the capsule is easy to swallow and preferred over other capsule endoscopy systems.2
  • Diagnostic Confidence: Designed for high-resolution, panoramic visualization of the small bowel mucosa, providing physicians with a comprehensive tool for detecting abnormalities.
  • Less Travel: With FDA clearance for remote ingestion, eligible patients can avoid clinic visits entirely. Patients can ingest the capsule from the comfort of their home and go about their day.
  • Comfort and Privacy: Eliminates the need for bulky, visible data recorders or adhesive devices, enabling patients to maintain their daily routines without disruption.
  • Improved Workflow: Streamlines the capsule endoscopy process and review with cloud-based video streaming and a user-friendly interface for easy interpretation of comprehensive images.
  • Expanded Care: The convenience of CapsoCam Plus makes it an ideal tool for telehealth, reducing the burden on both patients and healthcare providers while expanding access to care.

How It Works

Patients begin the process with a risk assessment questionnaire. During a scheduled virtual visit, a healthcare provider verifies the patient’s readiness, checks the capsule packaging, and guides the patient through the ingestion process, providing real-time supervision to ensure a safe procedure. After ingestion, the provider monitors the patient remotely, with an accompanying adult present to assist if needed. This oversight ensures that patients can safely undergo capsule endoscopy procedures while remaining in the comfort of their homes.

A History of Excellence

Remote ingestion of CapsoCam Plus has been successfully implemented in medical centers serving patients in remote regions of Canada, with favorable outcomes reported.1 In 2020, CapsoVision received FDA enforcement discretion during the COVID-19 pandemic, allowing eligible patients in the U.S. to undergo at-home administration. The recent FDA clearance enables patients to continue using the capsule for remote ingestion beyond the initial flexibility granted during the pandemic. This milestone is underpinned by a robust protocol for remote ingestion, ensuring the same high standard of care patients receive in a clinical setting.

¹Remote Capsule Endoscopy: Outcomes and Feasibility (Journal of the Canadian Association of Gastroenterology, 2021).

2Comparison of CapsoCam® SV-1 to PillCam® SB2 in the Evaluation of Subjects with Suspected Small Bowel Disease – 510K Clearance.